The FDA Safer Technologies Program (STeP), a collaborative program, helps reduce the time needed to develop and earn ...

NeuroPace announced preliminary one-year results from its clinical study evaluating neuromodulation therapy for generalized ...

AnX Robotica announced today that it received FDA 510(k) clearance for its MotiliCap technology with MotiliScan companion ...

Olympus announced that it received FDA 510(k) clearance for its EZ1500 series endoscopes featuring Extended Depth of Field ...

Salvia BioElectronics announced today that it completed a $60 million Series B financing round to support its migraine ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

Samsung Electronics' investment arm is in discussions to join a group of firms backing software and medical device company ...

Zimmer Biomet announced today that it appointed Kevin Thornal as group president, global businesses and the Americas.

BTIG analysts have downgraded (NYSE:GMED) from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

The technology provides effective bone resection in combination with a soft tissue protection feature. It delivers enhanced ...

The FDA issued a notice highlighting a letter issued by BD and its C.R. Bard subsidiary warning of new balloon device ...

German Bionic announced today that it launched the Exia AI-powered exoskeleton system, its most advanced wearable to date.